by alanine in two species of mycobacteria actively growing on chemically defined media was compared. In both instances, D-alanine was the most effective reversal agent. The specificity with which the D isomer reversed the antimycobacterial activity of D-cycloserine was more pronounced than that observed with other species of bacteria. Mycobactin, a growth factor for certain mycobacteria, showed no reversal activity.
The finding that D-4-amino-3-isoxazolidinone (D-cycloserine) acts as a competitive antagonist of D-alanine in certain bacteria has been well documented (Bondi, Kornblum, and Forte, 1957; Strominger, Threnn, and Scott, 1959; Shockman, 1959; Zygmunt, 1962) . D-Cycloserine is employed primarily as a chemotherapeutic agent in tuberculosis, and yet there is little available information on the mechanism by which D-cycloserine inhibits the growth of mycobacteria. Sutton and Stanfield (1955) observed that the antibacterial activity of D-cycloserine for Mycobacterium paratuberculosis was reversed by mycobactin, a growth factor for mycobacteria. The structure of mycobactin (Snow, 1954) , however, bears no obvious relationship to that of alanine. Recently, Morrison (1962) reported on the reversal of D-cycloserine inhibition of M. tuberculosis and M. phlei growth by D-alanine or D-alanine amide. Mycobactin was also reported to possess reversal activity, but no data were presented to support this conclusion, and the possible function of mycobactin as a reversal agent was not delineated. Earlier, Buogo et al. (1960) briefly described the reversal of D-cycloserine growth inhibition in M. smegmatis by D-alanine.
Since only limited information is available on the reversal of D-cycloserine inhibition of mycobacterial growth by alanine, it was of interest to study this problem further, and also to define more clearly the role of mycobactin as a possible reversal agent. Fig. 1 show the growth inhibition of Ml. butyricumn and Mf. phlei to graded concentrations of D-cycloserine. The minimal inhibitory concentrations (MIC) of the antibiotic for both cultures were about 10 ,ug/ml. These values comnpare closely with published values (5 to 20 ,ug/ml) for the in vitro inhibition of Al. tuberculosis. Selection of these mycobacteria for this work also appears appropriate on the basis of similarities in sensitivity to other antituberculosis agents. Under the experimental conditions employed, the MIC values for streptomycin sulfate and isoniazid were less than 5 ,ug/ml against both cultures.
MATERIALS
Whereas both Al. butyricum and Al. phlei are completely inhibited by 98 X 10-6 M D-Cycloserine, the latter bacterium is much less sensitive to lower concentrations of the antibiotic (Fig. 1) .
D-Alanine reversed the antibacterial activity of D-cycloserine more effectively than did either L-or DL-alanine in AII. butyricum (Table 1) . The specificity with which D-alanine reverses the antimycobacterial activity of D-oycloserine is much more pronounced than that previously observed with other bacteria (Bondi et al., 1957; Zygmunt, 1962) . At the concentrations of alanine employed (an 800-fold range) and of D-cycloserine, L-alanine was totally inactive. At lower concentrations of D-cycloserine, L-alanine showed some reversal activity, but it was always the leastactive form (Table 2) (Table   3 ).
Of the 23 amino acids tested for reversal of the antibacterial activity of D-cycloserine (98 X 10-6 M), alanine was the only one showing reversal activity in both mycobacteria. The following amino acids were inactive when tested as media supplements at a concentration of 1 mg/ml: ,-alanine; DL-a-aminobutyric acid, L-arginine HCI, DL-aspartic acid, L-cystine, DL-glutamic acid, L-glutamine, glycine, L-histidine HCl -H20, L-hydroxyproline, DL-isoleucine, DL-leucine, L-lysine, DL-methionine, DL-norvaline, DL-phenylalanine, L-proline, DL-serine, DL-threonine, DL- tryptophan, L-tyrosine, and DL-valine. In all cases, appropriate controls with the above media not supplemented with D-cycloserine were included.
In contrast with the results seen with D-alanine, mycobactin was found to possess no significant D-cycloserine reversal activity. Supplementation of M. butyricum flasks containing D-cycloserine (19.6, 29.4, 49 .0, and 98.0 X 10(-M) with mycobactin (1,000 mpg/ml) failed to reverse or diminish the antimycobacterial activity of D-cycloserine. This level of mycobactin is far in excess of the amount (30 m,ug/ml) needed for maximal growth of Ml. johnei (M. paratuberculosis). Nor was the growth inhibition of D-cycloserine (49.0 X 10-6 M) reversed by the addition of increased levels of mycobactin (5.0 pg/ml). With M. phlei, concentrations of mycobactin up to 5.0 ,g/ml also showed no D-cycloserine (98 X 10-6 M) reversal activity. Whereas mycobactin is an essential growth factor for M. johnei (M. paratuberculosis), it is only stimulatory for M. butyricum (Fig. 2) . In the work of Sutton and Stanfield (1955) , it was reported that a 4-week incubation period was necessary for maximal growth. However, the stability of D-cycloserine in a glycerol-asparagine-inorganic salts medium at an approximately neutral pH and a 37-C incubation for 1 month is questionable. t Alanine (M X 10-4).
On the basis of the available knowledge, it is suggested that D-cycloserine may inhibit two distinctly different phenomena in certain mycobacteria, namely, utilization of the growth factor, mycobactin (as postulated by others), and D-alanine utilization. Recent work by Snow (1961) Buogo et al. (1960) , Morrison (1962) , and the present study. The major amino acids of mycobacterial cell walls are alanine, diaminopimelic acid, and glutamic acid (Cummins and Harris, 1958; Belknap, Camien, and Dunn, 1961; Takeya, Hisatsune, and Nakashima, 1961) . Ikawa, Snell, and Lederer (1960) found that one-third of the alanine in M. tuberculosis var. hominis wax occurs as the D isomer, and that all of the alanine in the mycosides of M. avium and M. marianum are present as the D form. These studies then document a need in mycobacteria for D-alanine in cell-wall synthesis, and L-alanine for protein synthesis as well as for cell-wall synthesis. Previously (Zygmunt, 1962) 
